Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06985225 · ClinicalTrials.gov registry record

Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma

A clinical trial of Severe Asthma, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
5
Enrollment target
1
Study location

NCT06985225 is a study of Severe Asthma that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 5 participants, below the 3,854-participant average among 9 other Severe Asthma trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06985225, a study of Severe Asthma, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
5 participants
Enrollment target
1
Study location

Study Summary

In this study, xenon MRI will be used to evaluate regional functional consequences of mucus plugs in the lungs of patients with severe asthma. Mucus plugs will be identified using CT imaging, and xenon MRI will be used to evaluate ventilation and gas exchange impairments in regions of the lungs corresponding to the airways downstream of mucus plugs.

Conditions Studied

Interventions

  • COMBINATION_PRODUCT Hyperpolarized 129 Xenon

Study Locations (1)

Kansas

  • University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2025-06
Est. Completion 2026-12

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT06985225

The ClinicalTrials.gov registry entry for NCT06985225 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,854-participant average among 9 other Severe Asthma trials with a reported enrollment target (100% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Severe Asthma appearing as the primary indexed condition, and to 1 intervention - of which Hyperpolarized 129 Xenon is the first listed.

NCT06985225 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT06985225 about?

NCT06985225 is a clinical study titled "Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma". In this study, xenon MRI will be used to evaluate regional functional consequences of mucus plugs in the lungs of patients with severe asthma. Mucus plugs will be identified using CT imaging, and xenon MRI will be used to evaluate ventilation and gas exchange impairments in regions of the lungs corr...

What is the current status of trial NCT06985225?

This trial is currently recruiting. The enrollment target is 5 participants. The study started on 2025-06. Estimated completion is 2026-12.

What conditions does trial NCT06985225 study?

This clinical trial studies the following conditions: Severe Asthma.

What interventions are being tested in trial NCT06985225?

The interventions under investigation include: Hyperpolarized 129 Xenon (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT06985225?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06985225 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Severe Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.